Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab. - Al Rabadi, Luai S.; Cook, Madeline M.; Kaempf, Andy J.; Saraceni, Megan M.; Savin, Michael A.; Mitri, Zahi I. (BMC Cancer, 2021)